Alpha Cognition Inc.

ACOG · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 71 employees
50
SEC Filings
$6.34
Close 2026-06-01
71
Employees

Business Summary

PART I Business Overview We are a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease (AD), for which there are limited or no treatment options. We focus on the development of commercial manufacturing and commercial sales of ZUNVEYL oral tablet formulation. Our commercial development program for ZUNVEYL is primarily focused on building a long-term care (LTC) commercial team that can focus on providing key...

Latest Stock Quote

ACOG 2026-06-01 $6.34 O:$6.25 H:$6.38 L:$6.15 Vol:0.0M VWAP:$6.2845
origin leaf: 33d2412f725ae07cade1d238a6cee0cd8e942542589f33eb41fce0695133cef8

Next Earnings

Q2 FY2026 — expected 2026-08-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001213900-26-037614EDGAR105K words
2025-03-312024-12-310001213900-25-026225EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-110061EDGAR23K words
2025-08-142025-06-300001213900-25-076600EDGAR—
2025-05-152025-03-310001213900-25-044163EDGAR—
2024-11-142024-09-300001213900-24-098409EDGAR—
2024-08-122024-06-300001213900-24-067658EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001213900-26-035696EDGAR1K words
2026-03-260001213900-26-034778EDGAR—
2026-02-230001213900-26-019355EDGAR—
2026-01-150001213900-26-004765EDGAR—
2025-10-140001213900-25-098739EDGAR—
2025-10-020001213900-25-094911EDGAR—
2025-08-220001213900-25-080012EDGAR—
2025-06-230001213900-25-056752EDGAR—
2025-04-100001213900-25-030683EDGAR—
2025-02-270001213900-25-018138EDGAR—

50 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001655923
TickerACOG
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedA1
Websitehttps://www.alphacognition.com
Listed2021-06-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e0201a4acc15dbda47ebb32af7c320258006acba3d94539cbf7cda3adc76ee02
parent: 892b31e53b49f018683c848db1cbd5b59beb9ebe8580ed4c259023b6daad5f3a
content hash: b875048e1aa5cb6f37cb2f64ab16d79d65e80441031b8fa5e0561be71b31d8ff
signed: 2026-06-02T19:00:03.996Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf